logo

Magenta Therapeutics, Inc. (MGTA)



Trade MGTA now with
  Date
  Headline
9/15/2021 8:23:02 AM Magenta Therapeutics Announces IND Clearance For MGTA-117 Targeted Conditioning Clinical Trial
7/21/2021 8:07:10 AM Magenta Therapeutics Gets Clinical Hold Letter From FDA Regarding IND On Acute Myeloid Leukemia And MDS
7/6/2021 8:04:31 AM Magenta Therapeutics Appoints Caren Deardorf As Chief Commercial Officer
5/12/2021 10:08:40 AM Magenta Therapeutics To Sell Around 9,600,000 Shares To Certain Institutional Investors In A Private Placement
4/19/2021 8:04:19 AM Magenta Therapeutics Appoints David Nichols As Chief Technical Officer
12/7/2020 8:21:56 AM Magenta Therapeutics Announces Final Clinical Results From Its Earlier Completed Phase 1 Clinical Trial
12/4/2020 8:06:24 AM Magenta Therapeutics And Bluebird Bio Announce A Phase 2 Trial Collaboration To Evaluate Magenta's MGTA-145
11/9/2020 8:18:48 AM Magenta Therapeutics Appoints Steve Mahoney As Chief Financial And Operating Officer
11/5/2020 8:26:46 AM Magenta Therapeutics Q3 Net Loss $17.7 Mln Vs. Net Loss $21.0 Mln Last Year
8/6/2020 8:10:37 AM Magenta Therapeutics Q2 Net Loss $19.1 Mln Vs. Net Loss $17.7 Mln Last Year
6/15/2020 6:04:25 AM Magenta, Beam Therapeutics Announce Non-exclusive Collaboration Agreement To Evaluate Potential Utility Of MGTA-117
6/5/2020 8:34:06 AM Magenta Therapeutics Presents Data Supporting Immune Reset For Autoimmune Diseases
5/7/2020 7:58:36 AM Magenta Therapeutics Q1 Loss Per Share $0.51 Vs $0.44 Last Year
4/17/2020 8:16:03 AM Magenta Therapeutics Promotes John Davis To Head Of Research And Development And Chief Medical Officer